Omega-3 DHA in the Third Trimester for Infant Development

DHA is a long-chain omega-3 fatty acid that serves as a structural component of cell membranes, with particularly high concentrations in the brain and retina. Research into whether supplementing with DHA during pregnancy improves infant neurodevelopment or visual outcomes is ongoing, and current evidence is graded as insufficient by the NIH Office of Dietary Supplements.

What DHA Does in the Body

According to the NIH Office of Dietary Supplements, omega-3 fatty acids, including DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid), and ALA (alpha-linolenic acid), serve several well-established physiological roles. These include acting as structural components of the phospholipids that form cell membranes, providing a source of energy, and acting as precursors to eicosanoids, which are signaling molecules involved in cardiovascular, pulmonary, immune, and endocrine function. The evidence that DHA is especially concentrated in the retina, brain, and sperm is graded as strong by the NIH.

The third trimester is a period of rapid fetal brain and eye development. Because DHA accumulates in neural and retinal tissue, researchers have been interested in whether maternal DHA intake during this window influences infant outcomes. However, interest in a biological mechanism is not the same as proof that supplementation produces a measurable benefit, and that distinction matters when you are deciding what to take.

What the Evidence Actually Shows

It is important to read evidence grades carefully. The NIH Office of Dietary Supplements rates the claim that omega-3 DHA supplementation during pregnancy or infancy improves infant neurodevelopment or visual development as insufficient. That rating means the available studies have not yet produced consistent, high-quality results that allow a firm conclusion either way. It does not mean the idea has been disproven, but it does mean you should be cautious about any product or article that presents this benefit as settled science.

By contrast, the evidence that ALA is an essential fatty acid that must come from the diet is rated strong, and the evidence that long-chain omega-3 supplements lower elevated triglycerides is rated moderate. Keeping these distinctions clear helps you weigh what supplements can and cannot reliably do.

Intake Reference Values During Pregnancy

The Institute of Medicine, whose values are reported by the NIH Office of Dietary Supplements, set an Adequate Intake (AI) for total omega-3s expressed as ALA, not as DHA or EPA specifically. For women aged 19 to 50, the AI is 1.1 grams per day of ALA. No Recommended Dietary Allowance has been established because the data were not sufficient for the IOM to calculate an Estimated Average Requirement, which is the prerequisite for setting an RDA. Importantly, no specific intake recommendation exists for DHA or EPA as isolated nutrients.

The IOM did not set a Tolerable Upper Intake Level for any omega-3 fatty acid, meaning a formal safe upper boundary has not been defined from a dietary reference standpoint. The FDA does specify, however, that dietary supplement labels should not recommend a daily intake of EPA and DHA combined that exceeds 2 grams from supplements. This is a labeling guideline, not a clinical prescription limit, and your own clinician may advise differently based on your individual situation.

Food Sources to Consider First

Before reaching for a capsule, it is worth noting that DHA is available from food. Fatty fish such as salmon, sardines, and mackerel are among the richest sources. Plant foods provide ALA, found in flaxseed, chia seeds, and walnuts, but the conversion of ALA to DHA in the body is limited. Algae-based DHA supplements are an option for people who avoid fish. Discussing your diet with a registered dietitian or your obstetric provider is a reasonable first step before adding any supplement.

Safety and Side Effects

Omega-3s from food and supplements are generally regarded as safe, and the NIH Office of Dietary Supplements notes that no Tolerable Upper Intake Level has been set. Side effects from supplements are typically mild and may include an unpleasant taste, bad breath, bad-smelling sweat, headache, heartburn, nausea, stomach discomfort, or diarrhea. Taking capsules with meals or choosing enteric-coated products can reduce some of these effects for many people.

High doses, roughly 900 mg per day of EPA plus 600 mg per day of DHA or more taken over several weeks, may suppress inflammatory immune responses and reduce immune function, according to the NIH. This is relevant context for anyone considering high-dose products marketed specifically for pregnancy.

Drug and Supplement Interactions

Omega-3 fatty acids can reduce platelet aggregation and prolong bleeding time. If you are taking anticoagulant or antiplatelet medications such as warfarin, aspirin, or clopidogrel, or any other blood-thinning herbs or supplements, combining them with omega-3 supplements may theoretically increase bleeding risk. Clinical trials have generally shown that the prolongation of bleeding time did not exceed normal limits or cause clinically significant bleeding, but the NIH advises periodic monitoring. Talk to your doctor or pharmacist before combining omega-3 supplements with any medication. Prescription high-dose omega-3 products used to lower triglycerides are drug-strength doses and should be taken only under medical supervision.

A Note on Regulatory Status

Omega-3 dietary supplements are not intended to diagnose, treat, cure, or prevent any disease, and these statements have not been evaluated by the FDA. Supplements are also not required to demonstrate safety or efficacy before reaching store shelves, so looking for products that have been tested by a third-party verification program, such as USP or NSF, can add a layer of quality assurance.

Talking to Your Care Team

Because no specific DHA intake recommendation has been established by the IOM, and because the evidence for supplementation benefits in pregnancy remains insufficient, the most reliable path is a conversation with your obstetrician, midwife, or a registered dietitian. They can review your current diet, your prenatal vitamin formulation, any medications you take, and your overall health picture to give you guidance that applies to your specific circumstances. This guide is intended to help you arrive at that conversation better informed, not to replace it.

Sources

• NIH Office of Dietary Supplements: Omega-3 Fatty Acids Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
• NIH Office of Dietary Supplements: Omega-3 Fatty Acids Consumer Fact Sheet. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer/
• National Center for Complementary and Integrative Health: Omega-3 Supplements. https://www.nccih.nih.gov/health/omega3-supplements-what-you-need-to-know
• National Academies of Sciences: Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. https://nap.nationalacademies.org/catalog/10490/dietary-reference-intakes-for-energy-carbohydrate-fiber-fat-fatty-acids-cholesterol-protein-and-amino-acids